References
- Kupis W, Pałyga J, Tomal E, et al. The role of sirtuins in cellular homeostasis. J Physiol Biochem. 2016;72:371–380.
- Tennen RI, Berber E, Chua KF. Functional dissection of SIRT6: identification of domains that regulate histone deacetylase activity and chromatin localization. Mech Ageing Dev. 2010;131:185–192.
- Gao Y, Tan J, Jin J, et al. SIRT6 facilitates directional telomere movement upon oxidative damage. Sci Rep. 2018;8:5407.
- Mostoslavsky R, Chua KF, Lombard DB, et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell. 2006;124:315–329.
- Pan H, Guan D, Liu X, et al. SIRT6 safeguards human mesenchymal stem cells from oxidative stress by coactivating NRF2. Cell Res. 2016;26:190–205.
- Vazquez BN, Thackray JK, Serrano L. Sirtuins and DNA damage repair: SIRT7 comes to play. Nucleus. 2017;8:107–115.
- Giblin W, Skinner ME, Lombard DB. Sirtuins: guardians of mammalian healthspan. Trends Genet. 2014;30:271–286.
- Li X, Kazgan N. Mammalian sirtuins and energy metabolism. Int J Biol Sci. 2011;7:575–587.
- Li P, Jin Y, Qi F, et al. SIRT6 acts as a negative regulator in Dengue virus-induced inflammatory response by targeting the DNA binding domain of NF-κB p65. Front Cell Infect Microbiol. 2018;8:113.
- Kaeberlein M, McVey M, Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 1999;13:2570–2580.
- Tissenbaum HA, Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature. 2001;410:227–230.
- Wang Y, Tissenbaum HA. Overlapping and distinct functions for a Caenorhabditis elegans SIR2 and DAF-16/FOXO. Mech Ageing Dev. 2006;127:48–56.
- Rogina B, Helfand SL. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc Natl Acad Sci USA. 2004;101:15998–16003.
- Kanfi Y, Naiman S, Amir G, et al. The sirtuin SIRT6 regulates lifespan in male mice. Nature. 2012;483:218–221.
- Li Y, Qin J, Wei X, et al. Association of SIRT6 gene polymorphisms with human longevity. Iran J Public Health. 2016;45:1420–1426.
- Hirvonen K, Laivuori H, Lahti J, et al. SIRT6 polymorphism rs117385980 is associated with longevity and healthy aging in Finnish men. BMC Med Genet. 2017;18:41.
- TenNapel MJ, Lynch CF, Burns TL, et al. SIRT6 minor allele genotype is associated with >5-year decrease in lifespan in an aged cohort. PLoS ONE. 2014;9:e115616.
- Vitiello M, Zullo A, Servillo L, et al. Multiple pathways of SIRT6 at the crossroads in the control of longevity, cancer, and cardiovascular diseases. Ageing Res Rev. 2017;35:301–311.
- Khan RI, Nirzhor SSR, Akter R. A review of the recent advances made with SIRT6 and its implications on aging related processes, major human diseases, and possible therapeutic targets. Biomolecules. 2018;8:44.
- Lara E, Calvanese V, Fraga MF. Epigenetic drift and aging. In: Tollefsbol TO, editor. Epigenetics of aging. New York: Springer New York; 2010. p. 257–273. ISBN 978-1-4419-0639-7.
- Teschendorff AE, West J, Beck S. Age-associated epigenetic drift: implications, and a case of epigenetic thrift? Hum Mol Genet. 2013;22:R7–R15.
- Wallace RG, Twomey LC, Custaud MA, et al. Potential diagnostic and prognostic biomarkers of epigenetic drift within the cardiovascular compartment. Biomed Res Int. 2016;2016:2465763.
- Owczarz M, Budzinska M, Domaszewska-Szostek A, et al. miR-34a and miR-9 are overexpressed and SIRT genes are downregulated in peripheral blood mononuclear cells of aging humans. Exp Biol Med (Maywood). 2017;242:1453–1461.
- Budzinska M, Owczarz M, Pawlik-Pachucka E, et al. miR-96, miR-145 and miR-9 expression increases, and IGF-1R and FOXO1 expression decreases in peripheral blood mononuclear cells of aging humans. BMC Geriatr. 2016;16:200.
- Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–233.
- Gu W, Xu Y, Xie X, et al. The role of RNA structure at 5´ untranslated region in microRNA-mediated gene regulation. RNA. 2014;20:1369–1375.
- Liu B, Li J, Cairns MJ. Identifying miRNAs, targets, and functions. Brief Bioinform. 2014;15:1–19.
- Sharma A, Diecke S, Zhang WY, et al. The role of SIRT6 protein in aging and reprogramming of human induced pluripotent stem cells. J Biol Chem. 2013;288:18439–18447.
- Lefort K, Brooks Y, Ostano P, et al. A miR-34a-SIRT6 axis in the squamous cell differentiation network. Embo J. 2013;32:2248–2263.
- Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35:495–516.
- Gazin C, Wajapeyee N, Gobeil S, et al. An elaborate pathway required for Ras-mediated epigenetic silencing. Nature. 2007;449:1073–1077.
- Munitz A, Bachelet I, Finkelman FD, et al. CD48 is critically involved in allergic eosinophilic airway inflammation. Am J Respir Crit Care Med. 2007;175:911–918.
- Hoffman B, Liebermann DA. Apoptotic signaling by c-MYC. Oncogene. 2008;27:6462–6472.
- Lawson C, Wolf S. ICAM-1 signaling in endothelial cells. Pharmacol Rep. 2009;61:22–32.
- Lappas M. Anti-inflammatory properties of sirtuin 6 in human umbilical vein endothelial cells. Mediators Inflamm. 2012;2012:597514.
- Sundaresan NR, Vasudevan P, Zhong L, et al. The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun. Nat Med. 2012;18:1643–1650.
- Liu Y, He Y, Jin A, et al. Ribosomal protein-Mdm2-p53 pathway coordinates nutrient stress with lipid metabolism by regulating MCD and promoting fatty acid oxidation. Proc Natl Acad Sci USA. 2014;111:E2414–2422.
- Zhang P, Tu B, Wang H, et al. Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion. Proc Natl Acad Sci USA. 2014;111:10684–10689.
- Thirumurthi U, Shen J, Xia W, et al. MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer. Sci Signal. 2014;7:ra71.
- Zwaans BMM, Lombard DB. Interplay between sirtuins, MYC and hypoxia-inducible factor in cancer-associated metabolic reprogramming. Dis Model Mech. 2014;7:1023–1032.
- Shahni R, Cale CM, Anderson G, et al. Signal transducer and activator of transcription 2 deficiency is a novel disorder of mitochondrial fission. Brain. 2015;138:2834–2846.
- Ran L-K, Chen Y, Zhang -Z-Z, et al. SIRT6 overexpression potentiates apoptosis evasion in hepatocellular carcinoma via BCL2-associated X protein-dependent apoptotic pathway. Clin Cancer Res. 2016;22:3372–3382.
- Sipos F, Firneisz G, Műzes G. Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases. World J Gastroenterol. 2016;22:7938–7950.
- Riscal R, Schrepfer E, Arena G, et al. Chromatin-bound MDM2 regulates serine metabolism and redox homeostasis independently of p53. Mol Cell. 2016;62:890–902.
- Huang N, Liu Z, Zhu J, et al. Sirtuin 6 plays an oncogenic role and induces cell autophagy in esophageal cancer cells. Tumour Biol. 2017;39:1010428317708532.
- Garcia-Peterson LM, Ndiaye MA, Singh CK, et al. SIRT6 histone deacetylase functions as a potential oncogene in human melanoma. Genes Cancer. 2017;8:701–712.
- Wu D, Prives C. Relevance of the p53-MDM2 axis to aging. Cell Death Differ. 2018;25:169–179.
- Herskind AM, McGue M, Holm NV, et al. The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870–1900. Hum Genet. 1996;97:319–323.
- van Hjelmborg J, Iachine I, Skytthe A, et al. Genetic influence on human lifespan and longevity. Hum Genet. 2006;119:312–321.
- Sebastiani P, Solovieff N, Dewan AT, et al. Genetic signatures of exceptional longevity in humans. PLoS ONE. 2012;7:e29848.
- Beekman M, Nederstigt C, Suchiman HE, et al. Genome-wide association study (GWAS)-identified disease risk alleles do not compromise human longevity. Proc Natl Acad Sci USA. 2010;107:18046–18049.
- Passarino G, De Rango F, Montesanto A. Human longevity: genetics or lifestyle? It takes two to tango. Immun Ageing. 2016;13:12.
- Sahin K, Yilmaz S, Gozukirmizi N. Changes in human sirtuin 6 gene promoter methylation during aging. Biomed Rep. 2014;2:574–578.
- Ruan L, Chen J, Ruan L, et al. MicroRNA-186 suppresses lung cancer progression by targeting SIRT6. Cancer Biomark. 2018;21:415–423.
- Laxman N, Rubin C-J, Mallmin H, et al. Global miRNA expression and correlation with mRNA levels in primary human bone cells. RNA. 2015;21:1433–1443.
- Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol. 2010;11:252–263.
- Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science. 2007;318:1931–1934.
- Peshti V, Obolensky A, Nahum L, et al. Characterization of physiological defects in adult SIRT6-/- mice. PLoS ONE. 2017;12:e0176371.
- Michishita E, McCord RA, Berber E, et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature. 2008;452:492–496.
- Cardus A, Uryga AK, Walters G, et al. SIRT6 protects human endothelial cells from DNA damage, telomere dysfunction, and senescence. Cardiovasc Res. 2013;97:571–579.
- Nagai K, Matsushita T, Matsuzaki T, et al. Depletion of SIRT6 causes cellular senescence, DNA damage, and telomere dysfunction in human chondrocytes. Osteoarthr Cartil. 2015;23:1412–1420.
- Lee H-S, Ka S-O, Lee S-M, et al. Overexpression of sirtuin 6 suppresses inflammatory responses and bone destruction in mice with collagen-induced arthritis. Arthritis Rheum. 2013;65:1776–1785.
- Zhang N, Li Z, Mu W, et al. Calorie restriction-induced SIRT6 activation delays aging by suppressing NF-κB signaling. Cell Cycle. 2016;15:1009–1018.
- Roichman A, Kanfi Y, Glazz R, et al. SIRT6 overexpression improves various aspects of mouse healthspan. J Gerontol A Biol Sci Med Sci. 2017;72:603–615.
- Li M, Hou T, Gao T, et al. p53 cooperates with SIRT6 to regulate cardiolipin de novo biosynthesis. Cell Death Dis. 2018;9:941.
- Kastenhuber ER, Lowe SW. Putting p53 in context. Cell. 2017;170:1062–1078.
- Komarova EA, Krivokrysenko V, Wang K, et al. p53 is a suppressor of inflammatory response in mice. FASEB J. 2005;19:1030–1032.
- Gudkov AV, Komarova EA. p53 and the carcinogenicity of chronic inflammation. Cold Spring Harb Perspect Med. 2016;6:pii: a026161.
- Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69(Suppl 1):S4–S9.
- Dang CV. MYC, metabolism, cell growth, and tumorigenesis. Cold Spring Harb Perspect Med. 2013;3. DOI:10.1101/cshperspect.a014217
- Trop-Steinberg S, Azar Y. Is Myc an important biomarker? Myc expression in immune disorders and cancer. Am J Med Sci. 2018;355:67–75.
- Liu T, Zhou Y, Ko KS, et al. Interactions between Myc and mediators of inflammation in chronic liver diseases. Mediators Inflamm. 2015;2015:276850.
- Sebastián C, Zwaans BM, Silberman DM, et al. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell. 2012;151:1185‐1199.
- Mossakowska M, Broczek K, Wieczorowska-Tobis K, et al. Cognitive performance and functional status are the major factors predicting survival of centenarians in Poland. J Gerontol A Biol Sci Med Sci. 2014;69:1269–1275.
- Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged: the index of ADL: A standardized measure of biological and psychosocial function. JAMA. 1963;185:94–99.
- Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198.
- Polosak J, Roszkowska-Gancarz M, Kurylowicz A, et al. Decreased expression and the Lys751Gln polymorphism of the XPD gene are associated with extreme longevity. Biogerontology. 2010;11:287–297.
- Busk PK. A tool for design of primers for microRNA-specific quantitative RT-qPCR. BMC Bioinformatics. 2014;15:29.
- Takaoka A, Hayakawa S, Yanai H, et al. Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence. Nature. 2003;424:516–523.
- Hellebrekers DMEI, Melotte V, Viré E, et al. Identification of epigenetically silenced genes in tumor endothelial cells. Cancer Res. 2007;67:4138–4148.
- Huang H-P, Chen P-H, Yu C-Y, et al. Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogramming. J Biol Chem. 2011;286:33520–33532.
- Huang Q, Li L, Li L, et al. MDM2 knockdown mediated by a triazine-modified dendrimer in the treatment of non-small cell lung cancer. Oncotarget. 2016;7:44013–44022.
- Kim JA, Kim Y, Kwon B-M, et al. The natural compound cantharidin induces cancer cell death through inhibition of heat shock protein 70 (HSP70) and Bcl-2-associated athanogene domain 3 (BAG3) expression by blocking heat shock factor 1 (HSF1) binding to promoters. J Biol Chem. 2013;288:28713–28726.
- Mukaka MM. Statistics corner: A guide to appropriate use of correlation coefficient in medical research. Malawi Med J. 2012;24:69–71.